InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Zanganeh Maky. Insider active across 3 companies, notably Summit Therapeutics Inc.. In total, 3 disclosures have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €1.9m. History available since 12 May 2021. The latest transaction was filed on 16 August 2022 (Acquisition). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Zanganeh Maky is a declarant linked to Summit Therapeutics Inc., where he is Co-CEO & President, and to Pulse Biosciences, INC., where he is Director. He has 4 filings in total, and across the 4 sampled recent filings, the transactions are acquisitions with total buy volume of EUR 3551749, between 2021-05-14 and 2022-08-18, and EUR 0 in sales.